477 related articles for article (PubMed ID: 20007139)
21. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
[TBL] [Abstract][Full Text] [Related]
22. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
Foster K; Wang Y; Zhou D; Wright C
Cancer Chemother Pharmacol; 2009 Apr; 63(5):783-91. PubMed ID: 18641990
[TBL] [Abstract][Full Text] [Related]
23. Insulin-Like Growth Factor 1 Activates PI3k/Akt Signaling to Antagonize Lumbar Disc Degeneration.
Liu Z; Zhou K; Fu W; Zhang H
Cell Physiol Biochem; 2015; 37(1):225-32. PubMed ID: 26302720
[TBL] [Abstract][Full Text] [Related]
24. Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.
Wojtalla A; Salm F; Christiansen DG; Cremona T; Cwiek P; Shalaby T; Gross N; Grotzer MA; Arcaro A
PLoS One; 2012; 7(10):e47109. PubMed ID: 23056595
[TBL] [Abstract][Full Text] [Related]
25. Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison.
Nepstad I; Hatfield KJ; Aasebø E; Hernandez-Valladares M; Brenner AK; Bartaula-Brevik S; Berven F; Selheim F; Skavland J; Gjertsen BT; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2018 Jul; 22(7):639-653. PubMed ID: 29889583
[TBL] [Abstract][Full Text] [Related]
26. Role of androgen receptor on cyclic mechanical stretch-regulated proliferation of C2C12 myoblasts and its upstream signals: IGF-1-mediated PI3K/Akt and MAPKs pathways.
Ma Y; Fu S; Lu L; Wang X
Mol Cell Endocrinol; 2017 Jul; 450():83-93. PubMed ID: 28454723
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
28. The effects of mesenchymal stem cells on c-kit up-regulation and cell-cycle re-entry of neonatal cardiomyocytes are mediated by activation of insulin-like growth factor 1 receptor.
Yu XY; Geng YJ; Li XH; Lin QX; Shan ZX; Lin SG; Song YH; Li Y
Mol Cell Biochem; 2009 Dec; 332(1-2):25-32. PubMed ID: 19507001
[TBL] [Abstract][Full Text] [Related]
29. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
[TBL] [Abstract][Full Text] [Related]
30. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
[TBL] [Abstract][Full Text] [Related]
31. Microtia patients: Auricular chondrocyte ECM is promoted by CGF through IGF-1 activation of the IGF-1R/PI3K/AKT pathway.
Chen X; Zhang R; Zhang Q; Xu Z; Xu F; Li D; Li Y
J Cell Physiol; 2019 Dec; 234(12):21817-21824. PubMed ID: 30471105
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.
Jia G; Mitra AK; Gangahar DM; Agrawal DK
Exp Mol Pathol; 2010 Aug; 89(1):20-6. PubMed ID: 20471974
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
Serrano-López J; Serrano J; Figueroa V; Torres-Gomez A; Tabares S; Casaño J; Fernandez-Escalada N; Sánchez-Garcia J
Haematologica; 2013 Dec; 98(12):1877-85. PubMed ID: 23812937
[TBL] [Abstract][Full Text] [Related]
34. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
Li M; Chiu JF; Gagne J; Fukagawa NK
J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
[TBL] [Abstract][Full Text] [Related]
35. Involvement of IGF-1 and MEOX2 in PI3K/Akt1/2 and ERK1/2 pathways mediated proliferation and differentiation of perivascular adipocytes.
Liu P; Kong F; Wang J; Lu Q; Xu H; Qi T; Meng J
Exp Cell Res; 2015 Feb; 331(1):82-96. PubMed ID: 25239227
[TBL] [Abstract][Full Text] [Related]
36. The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor.
Xu G; Chu J; Shi Y; Huang L; Fu J
Growth Horm IGF Res; 2022 Oct; 66():101499. PubMed ID: 36084573
[TBL] [Abstract][Full Text] [Related]
37. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
38. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.
Wu YC; Zhu M; Robertson DM
PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999
[TBL] [Abstract][Full Text] [Related]
39. [Insulin-like growth factor 1 (IGF-1) promotes phagocytic activity of mouse BV-2 microglial cells via activating PI3K/AKT signaling pathway].
Zhai L; Chen X; Lu S; Yang D; Li W; Li F; Wu F; Sun M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Mar; 37(3):199-204. PubMed ID: 33766226
[TBL] [Abstract][Full Text] [Related]
40. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
